the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.
Also called NCT03230851
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 210 participants
- Registry
-
NCT03230851
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03230851. Randomized; single masking; primary purpose treatment. Start 2017-08-20 (anticipated); primary completion 2018-07-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy
- Condition
- Coronary Atherosclerosis
- Intervention (Drug)
- aspirin 100mg/d therapy
- Intervention (Drug)
- aspirin 100mg/2d therapy
- Intervention (Drug)
- aspirin 100mg/3d therapy
- Intervention (Drug)
- aspirin 50mg bid therapy
- Intervention (Drug)
- aspirin 75mg/d therapy
- Intervention (Drug)
- aspirin 50mg/d therapy
- Intervention (Drug)
- indobufen 100mg bid therapy
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
Record details
- Record id
cardio:ct-nct03230851- Content hash
a8235f39a8f82308954f34cff6ebf190f9cffce9ae9f6daf3cb1bb3d25a8fd73